Fortress Biotech, Inc. (FBIO) vs Verrica Pharmaceuticals Inc. (VRCA)

Fortress Biotech, Inc. and Verrica Pharmaceuticals Inc. are both Biotechnology companies. Fortress Biotech, Inc. and Verrica Pharmaceuticals Inc. are of similar size ($76.0M and $74.9M). Verrica Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.7×. Verrica Pharmaceuticals Inc. grew revenue faster over the last twelve months: 106.2% against 15.5%. Fortress Biotech, Inc. has the higher net margin (151.0% vs −102.8%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 17 metrics below, Fortress Biotech, Inc. leads on 13 and Verrica Pharmaceuticals Inc. on 4.

Valuation

Metric FBIO VRCA Biotechnology median
P/E 0.70 n/m 7.88
P/S 1.06 3.07 11.47
P/B 0.35 21.62 2.52
Price to free cash flow 0.84 n/m 21.16
EV/EBITDA 4.22 n/m 0.74
EV/Sales (1.25) 3.14 10.73
Earnings yield 142.98% (38.22%) (28.84%)
Free cash flow yield 118.43% (14.60%) (23.03%)

Profitability

Metric FBIO VRCA Biotechnology median
Gross margin 65.59% 85.89% 65.16%
Operating margin (42.61%) (93.59%) 0.00%
Net margin 150.98% (102.84%) 0.00%
Free cash flow margin 183.80% (44.02%) 0.00%
Return on equity 84.91% 473.29% (57.72%)
Return on assets 43.38% (83.02%) (49.22%)
Return on invested capital (41.34%) 0.00% 0.00%

Growth

Metric FBIO VRCA Biotechnology median
Revenue growth (TTM) 15.46% 106.21% 5.64%
EPS growth (last fiscal year) 97.40% 88.65% —
Revenue growth, 5-year CAGR 6.77% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FBIO VRCA Biotechnology median
Debt to equity 0.17 0.18 0.00
Current ratio 3.96 1.45 4.73
Net debt to EBITDA 0.43 2.59 0.96

Dividend

Metric FBIO VRCA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FBIO VRCA Biotechnology median
Market cap 76.04m 74.90m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack